|
A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor |
ASP0113 |
0113-CL-2001 |
NCT01974206 EudraCT 2013-000464-29 |
Transplantation, Kidney |
Phase 2 |
|
|
|
|
|
June 2022 |